4//SEC Filing
McHale Duncan 4
Accession 0001694665-23-000011
CIK 0001694665other
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 4:28 PM ET
Size
5.5 KB
Accession
0001694665-23-000011
Insider Transaction Report
Form 4
McHale Duncan
Chief Medical Officer
Transactions
- Award
Restricted Stock Units
2023-02-07+520,000→ 520,000 totalExercise: $0.00→ Common Stock (520,000 underlying)
Footnotes (1)
- [F1]The Restricted Stock Units vest in four (4) substantially equal quarterly installments following the February 07, 2023 grant date, such that all of the Restricted Stock Units will become vested on the first anniversary of the grant date, subject to the reporting person's continued service to the issuer on each such vesting date.
Documents
Issuer
Evelo Biosciences, Inc.
CIK 0001694665
Entity typeother
Related Parties
1- filerCIK 0001738896
Filing Metadata
- Form type
- 4
- Filed
- Feb 8, 7:00 PM ET
- Accepted
- Feb 9, 4:28 PM ET
- Size
- 5.5 KB